glucose, (beta-d)-isomer has been researched along with prolinedithiocarbamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senftleben, U | 1 |
| Chen, H; Hou, Y; Liang, D; Liu, Y; Lou, X | 1 |
1 review(s) available for glucose, (beta-d)-isomer and prolinedithiocarbamate
| Article | Year |
|---|---|
NF-kappaB in critical diseases: a bad guy?
Topics: Animals; Antioxidants; Critical Illness; Disease Models, Animal; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Mice; Multiple Organ Failure; NF-kappa B; Oxidation-Reduction; Proline; Signal Transduction; Thiocarbamates; Time Factors; Transcription Factors; Zymosan | 2003 |
1 other study(ies) available for glucose, (beta-d)-isomer and prolinedithiocarbamate
| Article | Year |
|---|---|
Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling.
Topics: Anthracenes; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Jurkat Cells; Lipopolysaccharides; NF-kappa B; Proline; Protein Kinase Inhibitors; Pyridines; Receptors, Tumor Necrosis Factor, Member 6b; Signal Transduction; Teichoic Acids; Thiocarbamates; Up-Regulation; Zymosan | 2018 |